Regulatory Due Diligence

Torrey Pines Law Group's regulatory attorneys and advisors have substantial experience with regulatory due diligence in the context of technology transactions, investment funding, corporate formation, and mergers and acquisitions. It is crucial for companies to thoroughly understand the laws and regulations that apply to the industry and the subject company or technology of the transaction. A misunderstanding could mean:

the loss of millions of dollars
immediate competition, versus years of market and data exclusivity
expedited approval of a drug or medical device, versus years of delay
a profitable investment, versus a flop

A number of issues can arise with FDA approvals and clearances, government licenses, technology licenses, third-party rights, and the competitive landscape. A number of other issues can arise with referral sources under Stark Laws and Anti-kickback laws and regulations. Other areas where scrutiny can be provided might be with the handling of Personally Identifiable Information (PII) and and Protected Health Information (PHI) under the US federal HIPAA laws and regulations as well as European GDPR.

Reviewing claims processing systems and controls to ensure that no billing improprieties or regulatory violations have occurred or are likely to occur. A number of other considerations have been analyzed by our team's attorneys and advisors.

For information on these and other legal, regulatory, and business matters, please contact us.

Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.

We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.